Skip to main content
. 2020 Jun 15;36(8):e3335. doi: 10.1002/dmrr.3335

TABLE 3.

Adverse events

Sitagliptin n = 19 Canaglifozin n = 17
Acute kidney injury 3 (15.8) 4 (23.5)
Arrhythmic events 1 (5.3) 1 (5.9)
Genital infections 1 (5.3) 1 (5.9)
Hypoglycemia 0 2 (11.8)
Hypotensive events 1 (5.3) 2 (11.8)
Rehospitalizations for any cause 1 (5.3) 1 (5.9)
Unplanned revascularizations 0 1 (5.9)
Worsening of heart failure 1 (5.3) 0